Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Chanaki Amaratunga

Dr Chanaki Amaratunga

Chanaki Amaratunga

DeTACT Coordinator

Chanaki Amaratunga is a Sri Lankan scientist who joined MORU in 2019 to coordinate the Development of Triple Artemisinin Combination Therapies (DeTACT) project. This is in line with her research interest of working on bench-to-bedside strategies for treating drug resistant malaria in low- and middle-income countries.

Chanaki obtained her PhD from the University of Colombo, Sri Lanka, working on the vaccinology and immunology of malaria. She did post-doctoral research on molecular biology and protein chemistry of malaria at the International Center of Genetic Engineering and Biotechnology, New Delhi, India.

Chanaki further trained at the Laboratory of Malaria and Vector Research (LMVR) at the National Institutes of Health (NIH), USA, where she worked on laboratory and clinical studies of drug resistant malaria and also served as the International Scientific Program Manager for LMVR/NIH.